Amoxicillin Bioveta LA

Important safety and use flags

• Hard stop: do not use with penicillin/beta-lactam hypersensitivity. Rare allergy can progress to anaphylactoid collapse; keep an emergency response immediately available and stop at urticaria, facial swelling, dyspnoea, vomiting, hypotension or collapse.
• Use only for a diagnosed or strongly suspected bacterial infection likely to be amoxicillin-susceptible. The exact label excludes penicillinase-producing organisms; plain amoxicillin does not cover beta-lactamase producers, resistant staphylococci, Pseudomonas or many Klebsiella/Enterobacter isolates.
• Exact dog dose is 10 mg/kg = 1 ml/15 kg IM once daily. LA supports at least 24 hours of active blood level; it does not authorise dosing less often than daily or treating an infection with one injection. Set course length by syndrome, source control and response.
• Obtain culture/susceptibility for recurrent, complicated, deep, severe, healthcare-associated, previously treated or poorly responding infection. Reassess diagnosis and therapy promptly if clinical improvement is absent or new lesions/signs develop.
• Do not treat a broad label category alone: respiratory signs, diarrhoea, urinary signs or a skin lesion are not proof of susceptible bacterial infection. Apply current syndrome-specific diagnostics, source control and stewardship; avoid prophylactic or unnecessarily prolonged courses.
• Shake thoroughly to a uniform suspension before every withdrawal. Use a dry sterile needle and syringe; water can hydrolyse the active. Do not mix in the same syringe or container with aqueous solutions or other medicines, and use aseptic multidose-vial technique.
• A transient local injection reaction can occur. Give IM only, rotate/record sites during a course and inspect for persistent pain, swelling, heat, sterile abscess or tissue injury. The historical exact instruction limits a site to 20 ml; usual canine doses are much smaller.
• Penicillins can be antagonised by bacteriostatic antibiotics such as tetracyclines or chloramphenicol. Do not combine routinely; if sequential or combined therapy is clinically justified, document pathogen, timing, compatibility and response.
• The exact label permits pregnancy and lactation without restriction, but amoxicillin crosses the placenta and is renally eliminated. Individualise benefit–risk and monitor more closely in renal dysfunction, dehydration, neonates or patients receiving other renally cleared drugs.
• Handler hazard: penicillins/cephalosporins can cause severe sensitisation after injection, inhalation, ingestion or skin contact. Sensitised staff should avoid handling; wear gloves, wash after use, avoid self-injection and obtain urgent care for swelling or breathing difficulty. Store below 25 °C, dry and light-protected; discard 28 days after opening.